Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
BMJ Open Diabetes Research & Care|October 1, 2020
Oral administration of NPC43 counters hyperglycemia and activates insulin receptor in streptozotocin-induced type 1 diabetic miceZi-Jian Lan, Zhenmin Lei, Lucinda Nation, et al.Breast Cancer Research and Treatment|July 1, 2016
GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cellsZi-Jian Lan, YunHui Hu, Sheng Zhang, et al.Cancer Science|February 24, 2015
Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancerJiao Li, Wei Su, Sheng Zhang, et al.Cellular and Molecular Life Sciences : CMLS|August 6, 2019
Non-peptidyl small molecule, adenosine, 5'-Se-methyl-5'-seleno-, 2',3'-diacetate, activates insulin receptor and attenuates hyperglycemia in type 2 diabetic Leprdb/db miceZi-Jian Lan, Zhenmin Lei, Alexandros Yiannikouris, et al.Biology of Reproduction|January 15, 2016
Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and DifferentiationShengqiang Li, Andrew K Moore, Jia Zhu, et al.Cell Proliferation|May 31, 2024
AAV-mediated gene therapy restores natural fertility and improves physical function in the Lhcgr-deficient mouse model of Leydig cell failureSuyuan Zhang, Bin Yang, Xiaoting Shen, et al.Cell Reports. Medicine|October 21, 2022
AAV-mediated gene therapy produces fertile offspring in the Lhcgr-deficient mouse model of Leydig cell failureKai Xia, Fulin Wang, Xingqiang Lai, et al.Nature Medicine|January 9, 2018
Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.Nature Medicine|April 11, 2018
Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuryEnrico Velardi, Jennifer J Tsai, Stefan Radtke, et al.Pageof 5